Re: Chicharros USA - bolsa internacional
Sophiris Bio Reports Successful Results from Completed Phase 2a Study of Topsalysin in Localized Prostate Cancer
http://investor.sophirisbio.com/releasedetail.cfm?ReleaseID=975147
Topsalysin successfully ablated tumor cells in patients with clinically significant localized disease
All 18 patients enrolled completed the study. Biopsy data at six months following treatment showed that:
- Two men experienced complete ablation of their targeted tumor with no evidence of any tumor remaining at 6 months;
- Seven men experienced a partial response, defined as either a reduction in the maximum cancer core length or a reduction in Gleason pattern;
- Nine patients had no response to treatment.
SPHS